Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.980
+0.270 (5.73%)
Mar 11, 2025, 4:00 PM EST - Market closed
Vanda Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$16.50
Upside
+231.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +301.61% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +261.45% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +261.45% | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +261.45% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +261.45% | Dec 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +261.45% | Oct 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +161.04% | Aug 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +120.88% | Jul 11, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | +140.96% | Feb 25, 2022 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | +181.12% | Jan 14, 2021 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +181.12% | Oct 29, 2020 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | +181.12% | Jun 9, 2020 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +181.12% | Mar 12, 2020 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $19 | Hold → Strong Buy | Upgrades | $19 | +281.53% | Aug 1, 2019 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 6, 2019 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades $29 | Buy → Hold | Downgrades | $29 | +482.33% | Dec 11, 2018 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with StockAnalysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.